[1]Patent:EP1847537,2007,A1.Locationinpatent:Page/Pagecolumn7
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2006/142362,2006,A1Locationinpatent:Page/Pagecolumn13;16
[2]Locationinpatent:bodytextZbinden,KatrinGroebke;Anselm,Lilli;Banner,DavidW.;Benz,Joerg;Blasco,Francesca;Decoret,Guillaume;Himber,Jacques;Kuhn,Bernd;Panday,Narendra;Ricklin,Fabienne;Risch,Philippe;Schlatter,Daniel;Stahl,Martin;Thomi,Stefan;Unger,Robert;Haap,Wolfgang[EuropeanJournalofMedicinalChemistry,2009,vol.44,#7,p.2787-2795]
[1]Patent:US2006/106016,2006,A1.Locationinpatent:Page/Pagecolumn79
[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2008/86226,2008,A2Locationinpatent:Page/Pagecolumn87
[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/55951,2006,A2Locationinpatent:Page/Pagecolumn60
[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2007/259924,2007,A1Locationinpatent:Page/Pagecolumn37
[4]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/63113,2006,A2Locationinpatent:Page/Pagecolumn120
[5]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/63293,2006,A2Locationinpatent:Page/Pagecolumn50
[1]CurrentPatentAssignee:PFIZERINC-WO2006/100565,2006,A1Locationinpatent:Page/Pagecolumn15
Title: The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor.
Journal: Chemical biology & drug design 20070801